Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Stage IIA Pancreatic Cancer
  • Estrogen Receptor Negative
  • Acute Myeloid Leukemia
  • Stage IVB Colon Cancer
  • Brain Glioblastoma
  • Extensive Stage Small Cell Lung Carcinoma
  • Head and Neck Carcinoma
  • HER2/Neu Negative
  • Stage III Colon Cancer
  • Stage IV Bladder Cancer
  • Stage IIIA Esophageal Cancer
  • Stage III Rectal Cancer
  • Hormone-Resistant Prostate Cancer
  • Stage II Pancreatic Cancer
  • Stage IIIA Ovarian Cancer
  • Stage IVB Rectal Cancer
  • Stage IV Non-small Cell Lung Cancer
  • Stage IIIB Skin Melanoma
  • Stage IIIC Esophageal Cancer
  • Stage II Rectal Cancer
  • Stage IV Esophageal Cancer
  • Stage IVA Rectal Cancer
  • Stage IV Pancreatic Cancer
  • Stage IV Renal Cell Cancer
  • Stage IIIB Colon Cancer
  • Limited Stage Small Cell Lung Carcinoma
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage IV Bone Sarcoma
  • Stage IVA Colon Cancer
  • Stage IIB Pancreatic Cancer
  • Stage IV Skin Melanoma
  • Stage IVA Bone Sarcoma
  • Stage IIIC Skin Melanoma
  • Stage IIIB Rectal Cancer
  • Stage IIIC Rectal Cancer
  • Stage IV Rectal Cancer
  • Stage IVB Bone Sarcoma
  • Stage IIIB Esophageal Cancer
  • Stage IIIB Gastric Cancer
  • Stage IIIC Ovarian Cancer
  • Stage IV Ovarian Cancer
  • Stage III Esophageal Cancer
  • Myelodysplastic Syndrome
  • Recurrent Carcinoma
  • Stage III Non-Small Cell Lung Cancer
  • Stage IV Soft Tissue Sarcoma
  • Stage III Ovarian Cancer
  • Stage III Gastric Cancer
  • Triple-Negative Breast Carcinoma
  • Stage IIIA Colon Cancer
  • Progesterone Receptor Negative
  • Stage IIIA Rectal Cancer
  • Stage IV Breast Cancer
  • Progressive Disease
  • Stage III Pancreatic Cancer
  • Stage IIIA Skin Melanoma
  • Stage IIIB Non Small Cell Lung Cancer
  • Stage IIIC Colon Cancer
  • Stage IIIA Gastric Cancer
  • Stage IV Gastric Cancer
  • Stage IIC Rectal Cancer
  • Stage III Skin Melanoma
  • Stage IIIC Gastric Cancer
  • Stage IV Colon Cancer
  • Stage IIIB Ovarian Cancer
  • Stage IIA Rectal Cancer
  • Stage IIB Rectal Cancer
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Health Services Research

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJ...

PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJECTIVES: I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive usual care. ARM B: Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms. After completion of study, patients are followed up for 6 months.

Tracking Information

NCT #
NCT03154190
Collaborators
Not Provided
Investigators
Principal Investigator: Manali Patel Stanford University